Catalyst Wire Dossier Catalyst Wire Dossier

Unspecified recombinant COVID-19 Omicron-Delta variant vaccine (CHO Cell)

· Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Unspecified recombinant COVID-19 Omicron-Delta variant vaccine (CHO Cell), covering 2022-11-15 to 2022-11-15. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) [Phase 3]

See pricing